Pregabalin treatment of anxiety in patients with substance use disorders.
Raza
Shafi
S
Siddiqui
Umar A
UA
Megna
James L
JL
Schwartz
Thomas L
TL
Batki
Steven L
SL
D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001007:Anxiety / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069583:Pregabalin; D019966:Substance-Related Disorders / Q000150:complications* / Q000523:psychology; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid